3.15
0.05 (1.61%)
| Previous Close | 3.10 |
| Open | 3.16 |
| Volume | 229,641 |
| Avg. Volume (3M) | 171,798 |
| Market Cap | 12,616,475 |
| 52 Weeks Range | |
| Earnings Date | 9 Aug 2023 - 14 Aug 2023 |
| Operating Margin (TTM) | -2,073.29% |
| Diluted EPS (TTM) | -1.43 |
| Quarterly Revenue Growth (YOY) | 2,170.70% |
| Total Debt/Equity (MRQ) | 121.86% |
| Current Ratio (MRQ) | 0.760 |
| Operating Cash Flow (TTM) | -9.30 M |
| Levered Free Cash Flow (TTM) | -4.11 M |
| Return on Assets (TTM) | -73.20% |
| Return on Equity (TTM) | -490.37% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Predictive Oncology Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.6 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 0.0 |
| Relative Valuation | NA |
| Financial Health | -4.0 |
| Macro Environment | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| Weighted Average | 0.33 |
Select this tab to load the latest available analysis.
|
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 1.27% |
| % Held by Institutions | 2.07% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |